Â鶹ÊÓƵ

Paul, Weiss is advising PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global integrated solutions provider and portfolio company of Kohlberg & Company, LLC, in its acquisition of Lyophilization Services of New England, Inc. (LSNE) from global private equity firm Permira. LSNE is a New Hampshire-based premier contract development and manufacturing organization (CDMO).

The transaction will expand PCI’s breadth of services as a global CDMO, building on PCI’s expertise in biologics packaging and specialty manufacturing. It will add five FDA-approved facilities in the U.S. and Europe, with a sixth expecting approval over the coming months, and three additional facilities under development, to PCI’s global 30-site network. Financial terms of the deal were not disclosed.

The Paul, Weiss team includes, among others, corporate partners Angelo BonvinoÌý²¹²Ô»åÌýThomas de la Bastide and counsel Julie Martinelli and Suhan Shim; tax partner Lindsay Parks; intellectual property partner Charles Googe; litigation partner Aidan Synnott and counsel Peter Jaffe and Steven Herzog; real estate partner Peter Fisch; executive compensation counsel Meghan Fox; international trade counsel Richard Elliott; and antitrust counsel Marta Kelly.